Interventional angiology

被引:0
作者
Steiner, Sabine [1 ]
机构
[1] Univ Klinikum Leipzig AoR, Dept Innere Med Neurol & Dermatol, Klin & Poliklin Angiol, Liebigstr 20, D-04103 Leipzig, Germany
来源
DIABETOLOGIE | 2023年 / 19卷 / 04期
关键词
Peripheral arterial disease; Endovascular procedures; Stents; Angioplasty; Restenosis; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; COATED BALLOON ANGIOPLASTY; CRITICAL LIMB ISCHEMIA; DRUG-ELUTING BALLOON; ARTERY-DISEASE; INFRAPOPLITEAL ARTERIES; REVASCULARIZATION; OUTCOMES; TRIAL; METAANALYSIS;
D O I
10.1007/s11428-023-01063-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There has been a significant increase in the prevalence of peripheral arterial disease (PAD) worldwide due to the aging population and the increase in relevant risk factors, especially diabetes. Due to technical and methodological improvements over the past 20 years, minimally invasive endovascular procedures are increasingly used when revascularization for PAD is required. Thus, even complex, long lesions can now be successfully treated using endovascular techniques. Recent data show better patency rates with the use of paclitaxel-eluting balloons and stents after femoropoliteal interventions, although safety concerns should be considered. Bypass surgery remains an important option for patients with advanced disease. An advantage for bypass surgery was reported in the BEST CLI study for the use of an adequate great saphenous vein in patients with chronic, limb-threatening ischemia. For selected patients in whom standard endovascular or surgical revascularization is not an option, the concept of endovascular arterialization of deep veins has been developed and investigated in multicenter studies.
引用
收藏
页码:425 / 432
页数:8
相关论文
共 38 条
  • [11] Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis
    Freisinger, Eva
    Malyar, Nasser M.
    Reinecke, Holger
    Lawall, Holger
    [J]. CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [12] Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial
    Goueffic, Yann
    Torsello, Giovanni
    Zeller, Thomas
    Esposito, Giovanni
    Vermassen, Frank
    Hausegger, Klaus Armin
    Tepe, Gunnar
    Thieme, Marcus
    Gschwandtner, Michael
    Kahlberg, Andrea
    Schindewolf, Marc
    Sapoval, Marc
    Diaz-Cartelle, Juan
    Stavroulakis, Konstantinos
    [J]. CIRCULATION, 2022, 146 (21) : 1564 - 1576
  • [13] Stenting or Surgery for De Novo Common Femoral Artery Stenosis
    Goueffic, Yann
    Della Schiava, Nellie
    Thaveau, Fabien
    Rosset, Eugenio
    Favre, Jean-Pierre
    du Mont, Lucie Salomon
    Alsac, Jean-Marc
    Hassen-Khodja, Reda
    Reix, Thierry
    Allaire, Eric
    Ducasse, Eric
    Soler, Raphael
    Guyomarc'h, Beatrice
    Nasr, Bahaa
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (13) : 1344 - 1354
  • [14] A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial
    Gray, William A.
    Keirse, Koen
    Soga, Yoshimitsu
    Benko, Andrew
    Babaev, Anvar
    Yokoi, Yoshiaki
    Schroeder, Henrik
    Prem, Jeffery T.
    Holden, Andrew
    Popma, Jeffrey
    Jaff, Michael R.
    Diaz-Cartelle, Juan
    Mueller-Huelsbeck, Stefan
    [J]. LANCET, 2018, 392 (10157) : 1541 - 1551
  • [15] Management of chronic peripheral artery disease patients with indication for endovascular revascularization A position paper by the European Society of Vascular Medicine
    Heiss, Christian
    Olinic, Dan-Mircea
    Belch, Jill J. F.
    Brodmann, Marianne
    Mazzolai, Lucia
    Stanek, Agata
    Madaric, Juraj
    Krentz, Andrew
    Schlager, Oliver
    Lichtenberg, Michael
    Frank, Ulrich
    [J]. VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2022, 51 (03) : 121 - 137
  • [16] Midterm Outcomes and Risk Stratification after Endovascular Therapy for Patients with Critical Limb Ischaemia due to Isolated Below-the-knee Lesions
    Iida, O.
    Soga, Y.
    Hirano, K.
    Kawasaki, D.
    Suzuki, K.
    Miyashita, Y.
    Nanto, S.
    Uematsu, M.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2012, 43 (03) : 313 - 321
  • [17] Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Katsanos, Konstantinos
    Spiliopoulos, Stavros
    Kitrou, Panagiotis
    Krokidis, Miltiadis
    Karnabatidis, Dimitrios
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (24):
  • [18] Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials
    Klumb, Christof
    Lehmann, Thomas
    Aschenbach, Rene
    Eckardt, Niklas
    Teichgraeber, Ulf
    [J]. ECLINICALMEDICINE, 2019, 16 : 42 - 50
  • [19] The Safety of Paclitaxel-Coated Devices for Patients with Peripheral Artery Disease
    Krawisz, Anna K.
    Secemsky, Eric A.
    [J]. CURRENT CARDIOLOGY REPORTS, 2021, 23 (05)
  • [20] Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions Five-Year Outcomes From the IN.PACT SFA Randomized Trial
    Laird, John A.
    Schneider, Peter A.
    Jaff, Michael R.
    Brodmann, Marianne
    Zeller, Thomas
    Metzger, D. Chris
    Krishnan, Prakash
    Scheinert, Dierk
    Micari, Antonio
    Wang, Hong
    Masters, Michele
    Tepe, Gunnar
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (06)